Drug: VELCADE Injury: Neuropathy peripheral Quarter: 2016Q3
Total Records: 85 Number of Pages: 5
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126007541 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | M | 0 | 20160727 | US |
126029302 | VELCADE | Neuropathy peripheral | TAKEDA | 59.91 YR | M | 71 KG | 20160818 | US |
126040082 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | 0 | 20160805 | JP | |
126048861 | VELCADE | Neuropathy peripheral | BAUSCH AND LOMB | 0.00 | F | 0 | 20160728 | GB |
126076701 | VELCADE | Neuropathy peripheral | TAKEDA | 66.00 YR | M | 125 KG | 20160729 | US |
126081061 | VELCADE | Neuropathy peripheral | BAUSCH AND LOMB | 69.00 YR | 0 | 20160729 | GB | |
126086351 | VELCADE | Neuropathy peripheral | CELGENE | 0.00 | M | 102 KG | 20160729 | US |
126163052 | VELCADE | Neuropathy peripheral | CELGENE | 0.00 | M | 79 KG | 20160914 | US |
126386001 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | F | 0 | 20160809 | US |
126539942 | VELCADE | Neuropathy peripheral | BAUSCH AND LOMB | 0.00 | M | 0 | 20160908 | GB |
126544251 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | F | 0 | 20160816 | US |
126573981 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | 0 | 20160816 | US | |
126585861 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | M | 0 | 20160817 | US |
126643681 | VELCADE | Neuropathy peripheral | CELGENE | 80.64 YR | F | 0 | 20160818 | US |
126643721 | VELCADE | Neuropathy peripheral | TAKEDA | 54.93 YR | M | 0 | 20160818 | CN |
126645431 | VELCADE | Neuropathy peripheral | TAKEDA | 71.12 YR | M | 0 | 20160818 | US |
126777572 | VELCADE | Neuropathy peripheral | CELGENE | 53.00 YR | F | 0 | 20160824 | US |
126882481 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | M | 0 | 20160826 | US |
126968281 | VELCADE | Neuropathy peripheral | TAKEDA | 0.00 | M | 0 | 20160830 | US |
127013931 | VELCADE | Neuropathy peripheral | MERCK | 0.00 | M | 0 | 20160831 | GB |
Total Records: 85 Number of Pages: 5